William Benton Jones Corvus Pharmaceuticals, Inc. (CRVS) insider trading activity

CRVS Quotes by TradingView

William Benton Jones is of Corvus Pharmaceuticals, Inc.. Currently has a direct ownership of 173,130 shares of CRVS, which is worth approximately $746,190. The most recent transaction as insider was on Jun 04, 2025, when has been sold 19,357 shares (Common Stock) at a price of $3.5 per share, resulting in proceeds of $67,749. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 173K
12.59% 3M change
12.59% 12M change
Total Value Held $746,190

William Benton Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
BUY
Exercise of conversion of derivative security
$67,749 $3.5 p/Share
19,357 Added 10.06%
173,130 Common Stock
May 06 2024
BUY
Open market or private purchase
$34,600 $1.73 p/Share
20,000 Added 11.51%
153,773 Common Stock
Dec 20 2022
BUY
Open market or private purchase
$15,800 $0.79 p/Share
20,000 Added 13.01%
133,773 Common Stock
WBJ

William Benton Jones

Burlingame, CA

Track Institutional and Insider Activities on CRVS

Follow Corvus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRVS shares.

Notify only if

Insider Trading

Get notified when an Corvus Pharmaceuticals, Inc. insider buys or sells CRVS shares.

Notify only if

News

Receive news related to Corvus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRVS